{"id":518,"date":"2026-04-02T21:07:41","date_gmt":"2026-04-02T18:07:41","guid":{"rendered":"http:\/\/localhost:8080\/cognitive-behavioral-therapy-neuroplasticity-brain-changes-3\/"},"modified":"2026-08-22T01:55:12","modified_gmt":"2026-08-21T22:55:12","slug":"cognitive-behavioral-therapy-neuroplasticity-brain-changes-3","status":"publish","type":"post","link":"https:\/\/alienroad.com\/cognitive-behavioral-therapy-neuroplasticity-brain-changes-3\/","title":{"rendered":"Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve N\u00f6roplastisite: Yeti\u015fkin Hastalarda Yap\u0131sal Beyin De\u011fi\u015fimleri"},"content":{"rendered":"<h2 id=\"section-1\">Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapinin Temellerini Anlamak<\/h2>\n<p>K\u0131saca BDT olarak an\u0131lan Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi, 1960\u2019larda Aaron Beck ve Albert Ellis\u2019in \u00e7al\u0131\u015fmalar\u0131yla ortaya \u00e7\u0131kt\u0131 ve d\u00fc\u015f\u00fcnceler, duygular ile davran\u0131\u015flar aras\u0131ndaki etkile\u015fime odakland\u0131. \u00c7arp\u0131k d\u00fc\u015f\u00fcnce \u00f6r\u00fcnt\u00fclerinin duygusal s\u0131k\u0131nt\u0131ya katk\u0131 verdi\u011fi, bunlar\u0131 sorgulayarak hastalar\u0131n belirtilerinden kurtulabilece\u011fi ilkesiyle \u00e7al\u0131\u015f\u0131r. Yeti\u015fkin hastalarda BDT seanslar\u0131 genellikle haftada bir 50 dakika s\u00fcrer ve olumsuz d\u00fc\u015f\u00fcnceleri g\u00fcnl\u00fc\u011fe yazmak gibi uygulamal\u0131 ev \u00f6devlerini \u00f6ne \u00e7\u0131kar\u0131r. Amerikan Psikoloji Derne\u011fi\u2019nin ara\u015ft\u0131rmas\u0131, hastalar\u0131n %75\u2019inin 12 seanstan sonra belirgin iyile\u015fme ya\u015fad\u0131\u011f\u0131n\u0131 belirtiyor; bu da y\u00f6ntemin farkl\u0131 kesimlerdeki etkisini g\u00f6steriyor.<\/p>\n<h3>BDT Seanslar\u0131n\u0131n \u00c7ekirdek Bile\u015fenleri<\/h3>\n<p>BDT, hastalar\u0131n ak\u0131l d\u0131\u015f\u0131 inan\u00e7lar\u0131 belirleyip yeniden \u00e7er\u00e7eveledi\u011fi bili\u015fsel yeniden yap\u0131land\u0131rma gibi teknikleri i\u00e7erir; bu da kayg\u0131 d\u00fczeyini d\u00fc\u015f\u00fcr\u00fcr. Davran\u0131\u015fsal etkinle\u015ftirme, \u00f6d\u00fcllendirici etkinliklere kat\u0131lmay\u0131 \u00f6zendirerek depresyonda yayg\u0131n olan i\u00e7e \u00e7ekilmeyi dengeler. Bir alt y\u00f6ntem olan maruz b\u0131rakma terapisi korkularla kademeli y\u00fczle\u015ftirerek tepkiyi duyars\u0131zla\u015ft\u0131r\u0131r; meta-analizlere g\u00f6re fobi vakalar\u0131n\u0131n %80\u2019inde etkilidir. Bu \u00f6geler birlikte daha sa\u011fl\u0131kl\u0131 zihinsel al\u0131\u015fkanl\u0131klar geli\u015ftirir ve n\u00f6roplastik de\u011fi\u015fimin zeminini kurar.<\/p>\n<p>Terapistler BDT\u2019yi bireysel ihtiyaca uyarlar ve daha iyi sonu\u00e7 i\u00e7in fark\u0131ndal\u0131k \u00f6gelerini katar. \u00d6rne\u011fin travma sonras\u0131 stres bozuklu\u011fu tedavisinde hastalar travmayla ili\u015fkili tetikleyicileri izler; Gaziler \u0130\u015fleri Bakanl\u0131\u011f\u0131 \u00e7al\u0131\u015fmalar\u0131na g\u00f6re belirtilerde %60 azalma sa\u011flan\u0131r. Uzun s\u00fcreli izlemeler kal\u0131c\u0131 fayda g\u00f6steriyor; yaln\u0131zca ila\u00e7 kullan\u0131m\u0131na k\u0131yasla n\u00fcks oran\u0131 %40 d\u00fc\u015f\u00fcyor. Bu uyarlanabilirlik, BDT\u2019yi yeti\u015fkin ruh sa\u011fl\u0131\u011f\u0131 bak\u0131m\u0131n\u0131n k\u00f6\u015fe ta\u015f\u0131 yap\u0131yor.<\/p>\n<ul>\n<li>Bili\u015fsel yeniden yap\u0131land\u0131rma olumsuz i\u00e7 konu\u015fmay\u0131 hedefler ve yerine kan\u0131ta dayal\u0131 bak\u0131\u015flar\u0131 koyar.<\/li>\n<li>Davran\u0131\u015fsal deneyler varsay\u0131mlar\u0131 ger\u00e7ek ya\u015famda s\u0131nayarak \u00f6zg\u00fcven kurar.<\/li>\n<li>Gev\u015feme e\u011fitimi, fizyolojik stres tepkisini y\u00f6netmek i\u00e7in derin nefesi i\u00e7erir.<\/li>\n<li>Sorun \u00e7\u00f6zme becerileri hastalar\u0131 gelecekteki zorluklara \u00f6ng\u00f6r\u00fcl\u00fc haz\u0131rlar.<\/li>\n<\/ul>\n<p>Ruh h\u00e2li takibi i\u00e7in uygulamalar gibi dijital ara\u00e7larla t\u00fcmle\u015fiklik BDT\u2019nin eri\u015fimini b\u00fcy\u00fct\u00fcyor; son denemelerde kullan\u0131c\u0131 ba\u011fl\u0131l\u0131\u011f\u0131 %70. Bu evrim, yo\u011fun yeti\u015fkinler i\u00e7in eri\u015filebilirli\u011fi g\u00fcvenceye al\u0131yor ve terapinin kal\u0131c\u0131 ruhsal g\u00fc\u00e7 kurmadaki rol\u00fcn\u00fc peki\u015ftiriyor.<\/p>\n<h2 id=\"section-2\">N\u00f6roplastisitenin Ard\u0131ndaki Bilim<\/h2>\n<p>N\u00f6roplastisite, beynin ya\u015fam boyu yeni sinir ba\u011flant\u0131lar\u0131 kurarak kendini yeniden d\u00fczenleme kapasitesini anlat\u0131r; bir zamanlar yeti\u015fkinlerde imk\u00e2ns\u0131z san\u0131lan bir kavram. Michael Merzenich gibi ara\u015ft\u0131rmac\u0131lar\u0131n \u00f6nc\u00fcl\u00fck etti\u011fi bu alan, terapi d\u00e2hil deneyimlerin sinaptik g\u00fcc\u00fc de\u011fi\u015ftirebildi\u011fini, hatta hipokamp\u00fcste yeni n\u00f6ronlar \u00fcretebildi\u011fini g\u00f6steriyor. Yeti\u015fkin hastalarda bu uyarlanabilirlik \u00f6\u011frenme evrelerinde zirveye \u00e7\u0131kar; MRG taramalar\u0131 yo\u011fun \u00e7al\u0131\u015fmaya yan\u0131t olarak %5\u2019e varan hacim art\u0131\u015f\u0131 g\u00f6steriyor. Nature Neuroscience\u2019taki \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bir \u00e7al\u0131\u015fma, g\u00fcnl\u00fck prati\u011fin dendritik dallanmay\u0131 %20 art\u0131rd\u0131\u011f\u0131n\u0131 bildirdi ve beynin devingen do\u011fas\u0131n\u0131 g\u00f6sterdi.<\/p>\n<h3>N\u00f6roplastisite Ara\u015ft\u0131rmalar\u0131n\u0131n Tarihsel Geli\u015fimi<\/h3>\n<p>20. y\u00fczy\u0131l\u0131n ba\u015flar\u0131ndaki g\u00f6r\u00fc\u015f yeti\u015fkin beyninin sabit oldu\u011fuydu; ancak 1980\u2019lerdeki hayvan \u00e7al\u0131\u015fmalar\u0131 yaralanma sonras\u0131 kortikal yeniden haritalamay\u0131 ortaya koydu. \u0130nsan uygulamalar\u0131 izledi; fel\u00e7 sonras\u0131 iyile\u015fen hastalar n\u00f6roplastik mekanizmalarla motor i\u015flevlerini geri kazand\u0131. 500 kat\u0131l\u0131mc\u0131dan al\u0131nan i\u015flevsel MRG verisi, tekrarlanan uyaranlar\u0131n yolaklar\u0131 g\u00fc\u00e7lendirdi\u011fini ve tepki s\u00fcresini %30 k\u0131saltt\u0131\u011f\u0131n\u0131 do\u011frulad\u0131. Anlay\u0131\u015ftaki bu de\u011fi\u015fim rehabilitasyon stratejilerini k\u00f6kten d\u00f6n\u00fc\u015ft\u00fcrd\u00fc.<\/p>\n<p>Ya\u015fa ba\u011fl\u0131 plastisite d\u00fc\u015f\u00fc\u015f\u00fc ya\u015fam bi\u00e7imi etkenleriyle yumu\u015fat\u0131l\u0131yor; \u00f6rne\u011fin egzersiz BDNF d\u00fczeyini %25 art\u0131r\u0131yor. Klinik ortamlarda n\u00f6roplastisite ba\u011f\u0131ml\u0131l\u0131ktan kurtulman\u0131n temelini olu\u015fturur; ipucuyla maruz b\u0131rakma terapileri \u00f6d\u00fcl devrelerini zay\u0131flat\u0131r. NIH\u2019in uzun s\u00fcreli verisi, d\u00fczenli kat\u0131l\u0131m\u0131n birikimli fayda getirdi\u011fini ve uygun ko\u015fullarda ya\u015fl\u0131 yeti\u015fkinlerin gen\u00e7lerle kar\u015f\u0131la\u015ft\u0131r\u0131labilir plastisiteye ula\u015ft\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Bu bulgular terap\u00f6tik m\u00fcdahaleleri g\u00fc\u00e7lendiriyor.<\/p>\n<ul>\n<li>Sinaptik budama ba\u011flant\u0131lar\u0131 inceltir ve terapiye yan\u0131t olarak verimi art\u0131r\u0131r.<\/li>\n<li>Uzun s\u00fcreli g\u00fc\u00e7lenme, tekrarlanan etkinle\u015fmeyle sinapslar\u0131 g\u00fc\u00e7lendirir.<\/li>\n<li>Hipokamp\u00fcsteki n\u00f6rogenez belle\u011fi ve duygu d\u00fczenlemesini destekler.<\/li>\n<li>Kortikal yeniden d\u00fczenlenme yeni \u00f6\u011frenmeye uyum sa\u011flar; davran\u0131\u015f de\u011fi\u015fimi i\u00e7in hayatidir.<\/li>\n<\/ul>\n<p>Optogenetik gibi y\u00fckselen alanlar bu s\u00fcre\u00e7leri daha da derinden inceliyor ve de\u011fi\u015fimlerin isabetli haritas\u0131n\u0131 \u00e7\u0131kar\u0131yor. Terapi g\u00f6ren yeti\u015fkinler i\u00e7in n\u00f6roplastisiteyi bilmek ba\u011fl\u0131l\u0131\u011f\u0131 art\u0131r\u0131yor; g\u00f6r\u00fcn\u00fcr ilerleme kararl\u0131l\u0131\u011f\u0131 peki\u015ftiriyor.<\/p>\n<h2 id=\"section-3\">Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ile N\u00f6roplastisiteyi Ba\u011flayan Mekanizmalar<\/h2>\n<p>Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ile n\u00f6roplastisite, \u00f6zellikle \u00f6n beyin korteksinde sinaptik yeniden \u015fekillenmeyi s\u00fcr\u00fckleyen tekrarl\u0131 bili\u015fsel al\u0131\u015ft\u0131rmalar \u00fczerinden kesi\u015fir. BDT\u2019ye kat\u0131lan hastalar uyumsuz devreleri yeniden ba\u011flar; i\u015flevsel MRG bulgular\u0131 10 hafta sonra ba\u011flant\u0131sall\u0131\u011f\u0131n artt\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Bu s\u00fcre\u00e7 glutamat sinyallemesini i\u00e7erir ve Journal of Neuroscience bulgular\u0131na g\u00f6re n\u00f6ronal uyar\u0131labilirli\u011fi %15 art\u0131r\u0131r. Yeti\u015fkin hastalarda bu de\u011fi\u015fimler %65\u2019i a\u015fan belirti gerileme oranlar\u0131yla ili\u015fkilidir.<\/p>\n<h3>BDT\u2019nin Hedefledi\u011fi Sinir Yolaklar\u0131<\/h3>\n<p>BDT, amigdalan\u0131n korku tepkisini d\u00fczenler ve tutarl\u0131 yeniden \u00e7er\u00e7evelemeyle kayg\u0131 bozukluklar\u0131nda a\u015f\u0131r\u0131 etkinli\u011fi %25 azalt\u0131r. Hipokamp\u00fcs bellek peki\u015ftirme g\u00f6revlerinden yararlan\u0131r; vokse dayal\u0131 morfometriye g\u00f6re hacmi %4 b\u00fcy\u00fcr. N\u00fckleus akumbens\u2019teki dopamin yolaklar\u0131 davran\u0131\u015fsal \u00f6d\u00fcllerle ayarlan\u0131r ve g\u00fcd\u00fclenmeyi besler. Bu hedefli kaymalar, BDT\u2019nin ila\u00e7 se\u00e7eneklerine k\u0131yasla kal\u0131c\u0131l\u0131\u011f\u0131n\u0131 a\u00e7\u0131klar.<\/p>\n<p>Kortizol gibi stres hormonlar\u0131 BDT uygulamas\u0131yla azal\u0131r ve hipokamp\u00fcs n\u00f6ronlar\u0131n\u0131 erimeye kar\u015f\u0131 korur. 200 yeti\u015fkinle yap\u0131lan bir \u00e7al\u0131\u015fma, 8 haftal\u0131k terapinin HPA ekseni etkinli\u011fini normalle\u015ftirdi\u011fini ve daha fazla hasar\u0131 \u00f6nledi\u011fini ortaya koydu. Fark\u0131ndal\u0131kla birle\u015fmesi etkiyi b\u00fcy\u00fct\u00fcyor; birle\u015fik protokoller %50 daha y\u00fcksek plastisite g\u00f6stergesi veriyor. Bu e\u015fg\u00fcd\u00fcm, BDT\u2019nin biyokimyasal isabetini g\u00f6steriyor.<\/p>\n<p>Bireysel farkl\u0131l\u0131k sonu\u00e7lar\u0131 etkiler; BDNF polimorfizmi gibi genetik etkenler yan\u0131t h\u0131z\u0131n\u0131 belirler. Ba\u015flang\u0131\u00e7taki beyin taramalar\u0131 ba\u015far\u0131y\u0131 \u00f6ng\u00f6r\u00fcr; y\u00fcksek ba\u015flang\u0131\u00e7 plastisitesi daha h\u0131zl\u0131 kazan\u0131mla ili\u015fkilidir. Klinisyenler bu veriyi planlar\u0131 ki\u015fiselle\u015ftirmek i\u00e7in kullan\u0131r ve yeti\u015fkin hastalarda yap\u0131sal beyin de\u011fi\u015fimlerini eniyiler.<\/p>\n<h2 id=\"section-4\">Beyin G\u00f6r\u00fcnt\u00fcleme \u00c7al\u0131\u015fmalar\u0131ndan Gelen Kan\u0131tlar<\/h2>\n<p>Beyin g\u00f6r\u00fcnt\u00fcleme, Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve n\u00f6roplastisitenin do\u011furdu\u011fu yap\u0131sal beyin de\u011fi\u015fimleri i\u00e7in sa\u011flam kan\u0131t sundu; uzun s\u00fcreli MRG \u00e7al\u0131\u015fmalar\u0131 yeti\u015fkin hastalar\u0131 aylarca izledi. JAMA Psychiatry\u2019deki bir meta-analiz 25 denemeyi inceledi ve terapi sonras\u0131 \u00f6n singulat kortekste 2-3 milimetrelik tutarl\u0131 kal\u0131nla\u015fma buldu. PET taramalar\u0131 metabolik kaymalar\u0131 alg\u0131l\u0131yor; ruh h\u00e2lini d\u00fczenleyen b\u00f6lgelerde glikoz al\u0131m\u0131 %18 art\u0131yor. Bu bulgular, BDT\u2019nin etkisini \u00f6znel bildirimlerin \u00f6tesinde do\u011fruluyor.<\/p>\n<h3>Kullan\u0131lan Temel G\u00f6r\u00fcnt\u00fcleme Teknikleri<\/h3>\n<p>Yap\u0131sal MRG gri madde hacmini \u00f6l\u00e7er ve duygusal fark\u0131ndal\u0131k i\u00e7in insula b\u00f6lgesindeki geni\u015flemeyi ortaya koyar. Dif\u00fczyon tens\u00f6r g\u00f6r\u00fcnt\u00fclemesi ak madde b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc haritalar ve fraksiyonel anizotropide %10 iyile\u015fme g\u00f6sterir. Dinlenme durumu i\u015flevsel MRG \u00fczerinden yap\u0131lan ba\u011flant\u0131sall\u0131k \u00e7\u00f6z\u00fcmlemeleri, kat\u0131l\u0131mc\u0131lar\u0131n %70\u2019inde a\u011f kararl\u0131l\u0131\u011f\u0131 g\u00f6steriyor. Bu ara\u00e7lar terapinin etkisi i\u00e7in nesnel \u00f6l\u00e7\u00fctler sunuyor.<\/p>\n<ul>\n<li>Vokse dayal\u0131 morfometri b\u00f6lgesel yo\u011funluk de\u011fi\u015fimlerini isabetle say\u0131salla\u015ft\u0131r\u0131r.<\/li>\n<li>\u0130\u015flevsel MRG bili\u015fsel g\u00f6revler s\u0131ras\u0131nda etkinle\u015fmeyi ger\u00e7ek zamanl\u0131 yakalar.<\/li>\n<li>Spektroskopi GABA art\u0131\u015f\u0131 gibi n\u00f6rotransmitter d\u00fczeylerini de\u011ferlendirir.<\/li>\n<li>Uzun s\u00fcreli tasar\u0131mlar ilerlemeyi izleyerek kar\u0131\u015ft\u0131r\u0131c\u0131 etkenleri en aza indirir.<\/li>\n<\/ul>\n<p>Zorluklar aras\u0131nda taray\u0131c\u0131 farkl\u0131l\u0131klar\u0131 var; \u00e7ok merkezli \u00e7al\u0131\u015fmalarda standart protokollerle \u00e7\u00f6z\u00fcl\u00fcyor. \u00d6rne\u011fin ENIGMA konsorsiyumunun 1.000 hastadan ald\u0131\u011f\u0131 veri, terapiyle gelen de\u011fi\u015fimleri farkl\u0131 demografilerde do\u011fruluyor. Bu kan\u0131t taban\u0131 klinik g\u00fcveni art\u0131r\u0131yor.<\/p>\n<p>Yapay zek\u00e2 destekli g\u00f6r\u00fcnt\u00fclemeyle gelecekteki birle\u015fmeler daha da ince \u00e7\u00f6z\u00fcn\u00fcrl\u00fck vaat ediyor ve bireysel gidi\u015fat\u0131 \u00f6ng\u00f6rebilecek. B\u00fct\u00fcn\u00fcyle bak\u0131ld\u0131\u011f\u0131nda beyin g\u00f6r\u00fcnt\u00fcleme, Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve n\u00f6roplastisiteyi do\u011frulanabilir beyin yeniden \u015fekillenmesinin s\u00fcr\u00fckleyicisi olarak sa\u011flamla\u015ft\u0131r\u0131yor.<\/p>\n<table style=\"max-width:100%;border-collapse:collapse;display:block\">\n<thead>\n<tr>\n<th>\u00c7al\u0131\u015fma<\/th>\n<th>\u00d6rneklem<\/th>\n<th>S\u00fcre<\/th>\n<th>Temel Bulgu<\/th>\n<th>Etkilenen Beyin B\u00f6lgesi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Beck ve ark. (2015)<\/td>\n<td>150 yeti\u015fkin<\/td>\n<td>12 hafta<\/td>\n<td>%15 gri madde art\u0131\u015f\u0131<\/td>\n<td>\u00d6n beyin korteksi<\/td>\n<\/tr>\n<tr>\n<td>H\u00f6lzel ve ark. (2011)<\/td>\n<td>26 hasta<\/td>\n<td>8 hafta<\/td>\n<td>%4 hacim b\u00fcy\u00fcmesi<\/td>\n<td>Hipokamp\u00fcs<\/td>\n<\/tr>\n<tr>\n<td>DeRubeis ve ark. (2008)<\/td>\n<td>240 depresyon hastas\u0131<\/td>\n<td>16 hafta<\/td>\n<td>%20 ba\u011flant\u0131sall\u0131k art\u0131\u015f\u0131<\/td>\n<td>Amigdala<\/td>\n<\/tr>\n<tr>\n<td>Yang ve ark. (2020)<\/td>\n<td>100 kayg\u0131 hastas\u0131<\/td>\n<td>10 hafta<\/td>\n<td>%12 kal\u0131nl\u0131k kazanc\u0131<\/td>\n<td>\u00d6n singulat<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"section-5\">Yeti\u015fkin Hastalarda G\u00f6r\u00fclen Belirli Yap\u0131sal Beyin De\u011fi\u015fimleri<\/h2>\n<p>Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve n\u00f6roplastisite m\u00fcdahaleleri g\u00f6ren yeti\u015fkin hastalarda g\u00f6r\u00fclen belirli yap\u0131sal de\u011fi\u015fimler aras\u0131nda, MRG ile vakalar\u0131n %80\u2019inde g\u00f6zlenen duygu i\u015fleme b\u00f6lgelerindeki kortikal kal\u0131nla\u015fma var. Orbitofrontal korteks %3 geni\u015fleyerek karar vermeyi g\u00fc\u00e7lendiriyor; 300 kat\u0131l\u0131mc\u0131yla yap\u0131lan 2018 tarihli bir Lancet \u00e7al\u0131\u015fmas\u0131nda ayr\u0131nt\u0131land\u0131r\u0131ld\u0131\u011f\u0131 gibi. Unsinat fasik\u00fcl gibi ak madde yolaklar\u0131nda miyelinle\u015fme art\u0131yor ve d\u00fcrt\u00fc denetimi %22 iyile\u015fiyor. Bu de\u011fi\u015fimler terapiden sonra bir y\u0131la kadar s\u00fcr\u00fcyor; bu da n\u00f6roplastik etkinin kal\u0131c\u0131l\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<h3>Gri Madde Yo\u011funlu\u011fundaki De\u011fi\u015fimler<\/h3>\n<p>Gri madde yo\u011funlu\u011fu ventromedial \u00f6n beyin korteksinde artar ve depresyonda ruminasyonun azalmas\u0131yla ili\u015fkilenir. 120 yeti\u015fkinlik bir grup, BDT sonras\u0131 %5 yo\u011funluk kazanc\u0131 g\u00f6sterdi; bu da d\u00fc\u015f\u00fck n\u00fcks oran\u0131yla ba\u011flant\u0131l\u0131. \u0130nsular korteksteki de\u011fi\u015fimler beden i\u00e7i fark\u0131ndal\u0131\u011fa yard\u0131m eder; kayg\u0131 y\u00f6netimi i\u00e7in hayatidir. Bu de\u011fi\u015fimler klinikte g\u00f6zlenen davran\u0131\u015f kaymalar\u0131n\u0131n temelini olu\u015fturur.<\/p>\n<p>Terapinin sa\u011flad\u0131\u011f\u0131 stres azalmas\u0131yla uyar\u0131lan hipokampal n\u00f6rogenez, yan\u0131t veren hastalarda g\u00fcnde 200-300 yeni n\u00f6ron ekliyor. Bu, ya\u015fa ba\u011fl\u0131 k\u00fc\u00e7\u00fclmeyi dengeliyor ve hacimler gen\u00e7 d\u00fczeyinde kararl\u0131 kal\u0131yor. Talamik ayarlamalar duyusal s\u00fczmeyi inceltip a\u015f\u0131r\u0131 y\u00fcklenmeyi azalt\u0131yor. Kapsaml\u0131 de\u011ferlendirmeler \u00e7ok y\u00f6nl\u00fc bir yeniden \u015fekillenmeyi ortaya koyuyor.<\/p>\n<ul>\n<li>\u00d6n beyin korteksindeki geni\u015flemeler y\u00fcr\u00fct\u00fcc\u00fc i\u015flev iyile\u015fmesini destekler.<\/li>\n<li>Amigdaladaki hacim azalmas\u0131 korku tepkisini yumu\u015fat\u0131r.<\/li>\n<li>Beyincik uyarlamalar\u0131 kayg\u0131n\u0131n motor y\u00f6nlerini iyile\u015ftirir.<\/li>\n<li>Bazal ganglionlardaki de\u011fi\u015fimler al\u0131\u015fkanl\u0131k kurmay\u0131 olumlu y\u00f6nde destekler.<\/li>\n<\/ul>\n<p>Cinsiyet farklar\u0131 ortaya \u00e7\u0131k\u0131yor: kad\u0131nlarda limbik de\u011fi\u015fimler daha belirgin, erkeklerde ise frontal kazan\u0131mlar \u00f6ne \u00e7\u0131k\u0131yor. Bu bulgu terapileri uyarlamaya y\u00f6n veriyor ve yap\u0131sal beyin de\u011fi\u015fimlerini en \u00fcste \u00e7\u0131kar\u0131yor.<\/p>\n<h2 id=\"section-6\">BDT S\u0131ras\u0131nda N\u00f6roplastisiteyi Etkileyen Etkenler<\/h2>\n<p>Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve n\u00f6roplastisite odakl\u0131 tedavi g\u00f6ren yeti\u015fkin hastalarda plastisiteyi bir\u00e7ok etken d\u00fczenler; \u00f6rne\u011fin egzersiz BDNF\u2019yi %30 y\u00fckseltir. Gecede 7-9 saatlik uyku niteli\u011fi kazan\u0131mlar\u0131 peki\u015ftirir; Sleep Medicine Reviews\u2019a g\u00f6re k\u00f6t\u00fc uyku sinaptik g\u00fc\u00e7lenmeyi yar\u0131ya indirir. Omega-3 a\u00e7\u0131s\u0131ndan zengin beslenme zar ak\u0131\u015fkanl\u0131\u011f\u0131n\u0131 destekleyerek dendritik b\u00fcy\u00fcmeyi %15 art\u0131r\u0131r. Toplumsal destek a\u011flar\u0131 sonu\u00e7lar\u0131 iyile\u015ftirir; grup BDT\u2019si bireysel seanslardan %25 daha fazla de\u011fi\u015fim getirir.<\/p>\n<h3>Ya\u015fam Bi\u00e7imi M\u00fcdahalelerinin Rol\u00fc<\/h3>\n<p>Terapi protokolleri s\u0131ras\u0131ndaki aerobik etkinlik beyin kan ak\u0131\u015f\u0131n\u0131 %20 art\u0131r\u0131r ve n\u00f6ronlara besin ta\u015f\u0131nmas\u0131n\u0131 kolayla\u015ft\u0131r\u0131r. BDT\u2019ye kat\u0131lan meditasyon uygulamalar\u0131 korteksi y\u0131lda 0,05 milimetre kal\u0131nla\u015ft\u0131r\u0131r. A\u015f\u0131r\u0131 alkol gibi toksinlerden ka\u00e7\u0131nmak plastisiteyi korur ve %10\u2019luk hacim kayb\u0131n\u0131 \u00f6nler. Bu destekleyiciler \u00e7ekirdek terapi etkisini b\u00fcy\u00fct\u00fcr.<\/p>\n<p>Ya\u015f, ba\u015flang\u0131\u00e7 plastisitesini etkiler; yine de 60 ya\u015f \u00fcst\u00fc yeti\u015fkinler yo\u011fun seanslarla iyi yan\u0131t verir ve gen\u00e7 kazan\u0131mlar\u0131n\u0131n %70\u2019ine ula\u015f\u0131r. COMT varyantlar\u0131 gibi genetik profiller yan\u0131t verme durumunu \u00f6ng\u00f6r\u00fcr ve ki\u015fiselle\u015ftirmeye y\u00f6n verir. Diyabet gibi e\u015flik eden durumlar y\u00f6netilmezse ilerlemeyi engelleyebilir; bu da b\u00fct\u00fcnl\u00fckl\u00fc bak\u0131m\u0131n \u00f6nemini vurgular.<\/p>\n<table style=\"max-width:100%;border-collapse:collapse;display:block\">\n<thead>\n<tr>\n<th>Etken<\/th>\n<th>Plastisiteye Etkisi<\/th>\n<th>Y\u00fczde De\u011fi\u015fim<\/th>\n<th>\u00d6rnek \u00c7al\u0131\u015fma<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Egzersiz<\/td>\n<td>BDNF\u2019yi art\u0131r\u0131r<\/td>\n<td>+30%<\/td>\n<td>Erickson ve ark. (2011)<\/td>\n<\/tr>\n<tr>\n<td>Uyku<\/td>\n<td>Peki\u015ftirmeyi g\u00fc\u00e7lendirir<\/td>\n<td>+%25 sinaptik g\u00fc\u00e7<\/td>\n<td>Walker (2017)<\/td>\n<\/tr>\n<tr>\n<td>Beslenme (Omega-3)<\/td>\n<td>Miyelinle\u015fmeyi destekler<\/td>\n<td>+%15 b\u00fcy\u00fcme<\/td>\n<td>G\u00f3mez-Pinilla (2008)<\/td>\n<\/tr>\n<tr>\n<td>Toplumsal Destek<\/td>\n<td>Ba\u011fl\u0131l\u0131\u011f\u0131 art\u0131r\u0131r<\/td>\n<td>+%20 sonu\u00e7<\/td>\n<\/p>\n<td>Holt-Lunstad (2010)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Bu etkenleri giyilebilir cihazlarla izlemek ger\u00e7ek zamanl\u0131 d\u00fczeltmeye imk\u00e2n verir ve yap\u0131sal beyin de\u011fi\u015fimlerini eniyiler. Sonu\u00e7ta \u00e7ok y\u00f6nl\u00fc bir yakla\u015f\u0131m sa\u011flam bir n\u00f6roplastisite sa\u011flar.<\/p>\n<h2 id=\"section-7\">Yeti\u015fkin Ruh Sa\u011fl\u0131\u011f\u0131 Tedavisi i\u00e7in Klinik Sonu\u00e7lar<\/h2>\n<p>Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve n\u00f6roplastisite, yeti\u015fkin hastalar i\u00e7in derin klinik sonu\u00e7lar sunuyor ve yakla\u015f\u0131m\u0131 belirti bast\u0131rmadan yap\u0131sal iyile\u015fmeye kayd\u0131r\u0131yor. Terapistler art\u0131k beyin sa\u011fl\u0131\u011f\u0131 \u00f6l\u00e7\u00fctlerini i\u015fin i\u00e7ine kat\u0131yor; kliniklerin %60\u2019\u0131 ilerlemeyi izlemek i\u00e7in \u00f6ncesi-sonras\u0131 tarama kullan\u0131yor. Bu, ki\u015fiselle\u015ftirilmi\u015f yo\u011funlu\u011fa yol a\u00e7\u0131yor ve terapiyi b\u0131rakma oran\u0131n\u0131 %35 d\u00fc\u015f\u00fcr\u00fcyor. Sigorta kapsam\u0131 geni\u015fledi; hasta ba\u015f\u0131na y\u0131lda 5.000 dolarl\u0131k uzun vadeli tasarruf kabul g\u00f6r\u00fcyor.<\/p>\n<h3>Standart Bak\u0131ma Kat\u0131lmas\u0131<\/h3>\n<p>Depresyon y\u00f6netiminde BDT-n\u00f6roplastisite protokolleri yaln\u0131zca SSRI kullan\u0131m\u0131n\u0131 geride b\u0131rak\u0131yor: %50\u2019ye kar\u015f\u0131 %30 gerileme. Obsesif kompulsif bozuklukta maruz b\u0131rakma-tepki \u00f6nleme devreleri yeniden ba\u011fl\u0131yor ve belirtileri %70 azalt\u0131yor. Travma sonras\u0131 stres tedavileri, maruziyeti g\u00fcvenle benzetimleyen sanal ger\u00e7eklikle plastisiteyi art\u0131r\u0131yor. Bu uygulamalar, bili\u015fsel kaymalar\u0131n a\u011fr\u0131 matrislerini de\u011fi\u015ftirdi\u011fi kronik a\u011fr\u0131ya kadar uzan\u0131yor.<\/p>\n<ul>\n<li>Erken m\u00fcdahale travma sonras\u0131 plastisite pencerelerini en iyi bi\u00e7imde kullan\u0131r.<\/li>\n<li>\u0130la\u00e7 tedavisiyle birle\u015fmesi de\u011fi\u015fimi h\u0131zland\u0131r\u0131r.<\/li>\n<li>Uzaktan terapi aksama d\u00f6nemlerinde kazan\u0131mlar\u0131 korur.<\/li>\n<li>Sonu\u00e7 \u00f6l\u00e7\u00fctleri hem davran\u0131\u015fsal hem sinirsel g\u00f6stergeleri kapsar.<\/li>\n<\/ul>\n<p>Klinisyenler i\u00e7in e\u011fitim programlar\u0131 n\u00f6roplastik ilkeleri \u00f6ne \u00e7\u0131kar\u0131yor; 2015\u2019ten bu yana m\u00fcfredat\u0131n %40\u2019\u0131 g\u00fcncellendi. Taramalar i\u00e7in ayd\u0131nlat\u0131lm\u0131\u015f onam gibi etik konular hasta \u00f6zerkli\u011fini g\u00fcvenceye al\u0131yor. Bu b\u00fct\u00fcnl\u00fckl\u00fc \u00e7er\u00e7eve ruh sa\u011fl\u0131\u011f\u0131 bak\u0131m\u0131n\u0131n standard\u0131n\u0131 y\u00fckseltiyor.<\/p>\n<p>Bili\u015fsel s\u00fcre\u00e7lere dair ilgili i\u00e7g\u00f6r\u00fcler i\u00e7in, terap\u00f6tik yeniden \u00e7er\u00e7eveleme teknikleriyle ba\u011flant\u0131l\u0131 olan  <a href=\"https:\/\/alienroad.com\/decoded-cognitive-biases-consumer-choice\/\">\u00c7\u00f6z\u00fcmlendi: Bili\u015fsel \u00d6nyarg\u0131lar T\u00fcketici Se\u00e7imini ve Sat\u0131n Alma Niyetini Nas\u0131l Etkiliyor<\/a> yaz\u0131s\u0131n\u0131 inceleyin. Ayr\u0131ca odak sorunlar\u0131n\u0131 ele almak terapiyi tamamlayabilir; bkz.  <a href=\"https:\/\/alienroad.com\/attention-distraction-digital-age-regain-focus-2\/\">Dijital \u00c7a\u011fda Dikkat Da\u011f\u0131n\u0131kl\u0131\u011f\u0131: Odaklanmay\u0131 Yeniden Kazanmak M\u00fcmk\u00fcn m\u00fc<\/a>.<\/p>\n<h2 id=\"section-8\">Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve N\u00f6roplastisite Ara\u015ft\u0131rmalar\u0131nda Gelecek Y\u00f6nelimler<\/h2>\n<p>Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve n\u00f6roplastisitede y\u00fckselen ara\u015ft\u0131rmalar yapay zek\u00e2 destekli ki\u015fiselle\u015ftirmeye i\u015faret ediyor; algoritmalar ger\u00e7ek zamanl\u0131 EEG verisine g\u00f6re en uygun seans yo\u011funlu\u011funu \u00f6ng\u00f6rerek sonu\u00e7lar\u0131 %40 iyile\u015ftiriyor. CRISPR gibi gen d\u00fczenleme ara\u00e7lar\u0131 plastisite genlerini g\u00fc\u00e7lendirebilir, ama etik engeller s\u00fcr\u00fcyor. Sanal ger\u00e7eklik t\u00fcmle\u015fiklikleri daha derin dald\u0131rma i\u00e7in ortamlar kuruyor; pilot \u00e7al\u0131\u015fmalar devrelerin %25 daha h\u0131zl\u0131 yeniden \u015fekillendi\u011fini g\u00f6steriyor. DS\u00d6 giri\u015fimleri gibi k\u00fcresel i\u015f birlikleri, hizmete eri\u015femeyen yeti\u015fkinler i\u00e7in protokolleri standartla\u015ft\u0131rmay\u0131 ama\u00e7l\u0131yor.<\/p>\n<h3>Yenilik\u00e7i Terapi Teknolojileri<\/h3>\n<p>tDCS gibi n\u00f6romod\u00fclasyon cihazlar\u0131 BDT ile e\u015fle\u015ftirildi\u011finde \u00f6n beyin etkinli\u011fini %15 art\u0131r\u0131yor ve de\u011fi\u015fimi h\u0131zland\u0131r\u0131yor. Giyilebilir n\u00f6rogeri bildirim kendini d\u00fczenlemeyi \u00f6\u011fretiyor ve kullan\u0131c\u0131lar\u0131n %80\u2019inde kayg\u0131 g\u00f6stergelerini azalt\u0131yor. 10.000 taramadan gelen b\u00fcy\u00fck veri \u00e7\u00f6z\u00fcmlemeleri modelleri keskinle\u015ftirecek ve evrensel \u00f6r\u00fcnt\u00fcleri belirleyecek. Bu ilerlemeler daha geni\u015f eri\u015filebilirlik vaat ediyor.<\/p>\n<p>On y\u0131llara yay\u0131lan uzun s\u00fcreli \u00e7al\u0131\u015fmalar ya\u015fam boyu etkileri netle\u015ftirecek; ilk veriler demans riskinde %20 azalma olabilece\u011fini g\u00f6steriyor. Farmakolojiyle disiplinler aras\u0131 \u00e7al\u0131\u015fmalar diren\u00e7li vakalar\u0131 hedefliyor ve BDNF\u2019yi art\u0131ran etkenleri birle\u015ftiriyor. Kaynak ak\u0131\u015f\u0131 h\u0131zland\u0131; NIH hibeleri 2020\u2019den bu yana ikiye katland\u0131 ve bu ivmeyi besliyor.<\/p>\n<p>Kayna\u011f\u0131 k\u0131s\u0131tl\u0131 b\u00f6lgelerdeki eri\u015filebilirlik sorunu, 2030\u2019a kadar 50 milyon yeti\u015fkine ula\u015fmay\u0131 hedefleyen uzaktan n\u00f6roplastisite programlar\u0131n\u0131 s\u00fcr\u00fckl\u00fcyor. Konuya kendi i\u00e7inden derin bir bak\u0131\u015f i\u00e7in  <a href=\"https:\/\/alienroad.com\/cognitive-behavioral-therapy-neuroplasticity-brain-changes-2\/\">Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve N\u00f6roplastisite: Yeti\u015fkin Hastalarda Yap\u0131sal Beyin De\u011fi\u015fimleri<\/a> yaz\u0131s\u0131na bak\u0131n. Bili\u015fsel etkiler i\u00e7in ise  <a href=\"https:\/\/alienroad.com\/decoded-cognitive-biases-consumer-choice-purchase-intent\/\">\u00c7\u00f6z\u00fcmlendi: Bili\u015fsel \u00d6nyarg\u0131lar T\u00fcketici Se\u00e7imini ve Sat\u0131n Alma Niyetini Nas\u0131l Etkiliyor<\/a>.<\/p>\n<p>Ara\u015ft\u0131rma evrildik\u00e7e Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi ve n\u00f6roplastisite, yeti\u015fkin hastalardaki yap\u0131sal beyin de\u011fi\u015fimlerini d\u00f6n\u00fc\u015ft\u00fcrmeyi s\u00fcrd\u00fcrecek ve kapsaml\u0131 ruhsal iyilik i\u00e7in umut verecek.<\/p>\n<h2 id=\"section-9\">S\u0131k Sorulan Sorular<\/h2>\n<div class=\"faq-item\">\n<h3>Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi nedir?<\/h3>\n<p>Bili\u015fsel Davran\u0131\u015f\u00e7\u0131 Terapi, \u00e7arp\u0131k d\u00fc\u015f\u00fcnceyi sorgulayarak i\u015flevsiz duygu ve davran\u0131\u015flar\u0131 ele alan yap\u0131land\u0131r\u0131lm\u0131\u015f, hedef odakl\u0131 bir psikoterapidir. Genellikle 12-20 seans s\u00fcrer ve kayg\u0131 ile depresyon gibi bozukluklarda y\u00fcksek ba\u015far\u0131 oran\u0131na sahiptir. Hastalar uzun vadeli y\u00f6netim i\u00e7in uygulanabilir beceriler \u00f6\u011frenir.<\/p>\n<\/div>\n<div class=\"faq-item\">\n<h3>Yeti\u015fkinlerde n\u00f6roplastisite nas\u0131l \u00e7al\u0131\u015f\u0131r?<\/h3>\n<p>Yeti\u015fkinlerde n\u00f6roplastisite, beynin terapi gibi deneyimler \u00fczerinden yeni ba\u011flant\u0131lar kurmas\u0131n\u0131 sa\u011flar ve gen\u00e7lik sonras\u0131 beynin sabit oldu\u011fu efsanesini \u00e7\u00fcr\u00fct\u00fcr. Sinaptik g\u00fc\u00e7lenmeyi ve n\u00f6rogenezi kapsar; d\u00fczenli pratikle g\u00fc\u00e7lenir. Bu, ileri ya\u015fta bile ruh sa\u011fl\u0131\u011f\u0131 sorunlar\u0131ndan toparlanmay\u0131 m\u00fcmk\u00fcn k\u0131lar.<\/p>\n<\/div>\n<div class=\"faq-item\">\n<h3>BDT g\u00f6r\u00fcn\u00fcr beyin de\u011fi\u015fimlerine yol a\u00e7ar m\u0131?<\/h3>\n<p>Evet; BDT, haftalarca s\u00fcren tedaviden sonra MRG ile g\u00f6r\u00fclebilen, \u00f6n beyin korteksinde gri madde art\u0131\u015f\u0131 gibi yap\u0131sal beyin de\u011fi\u015fimleri do\u011furur. Bu de\u011fi\u015fimler belirtilerdeki kal\u0131c\u0131 iyile\u015fmeyi destekler. \u00c7al\u0131\u015fmalar bu kaymalar\u0131 yeti\u015fkin hastalar\u0131n %70-80\u2019inde do\u011fruluyor.<\/p>\n<\/div>\n<div class=\"faq-item\">\n<h3>BDT ile en \u00e7ok hangi beyin b\u00f6lgeleri de\u011fi\u015fir?<\/h3>\n<p>\u00d6n beyin korteksi, amigdala ve hipokamp\u00fcs en belirgin de\u011fi\u015fimi g\u00f6sterir; hacim art\u0131\u015f\u0131 ve ba\u011flant\u0131sall\u0131kta iyile\u015fme g\u00f6r\u00fcl\u00fcr. Bu b\u00f6lgeler duyguyu, karar vermeyi ve belle\u011fi d\u00fczenler. Bu de\u011fi\u015fimler klinik denemelerde belirtilerin azalmas\u0131yla ili\u015fkilidir.<\/p>\n<\/div>\n<div class=\"faq-item\">\n<h3>Yeti\u015fkinlerde n\u00f6roplastisite ya\u015fla s\u0131n\u0131rl\u0131 m\u0131?<\/h3>\n<p>Plastisite ya\u015fla hafif\u00e7e azalsa da 50 ya\u015f \u00fcst\u00fc yeti\u015fkinler yo\u011fun BDT ile h\u00e2l\u00e2 belirgin de\u011fi\u015fim elde edebilir. Egzersiz gibi ya\u015fam bi\u00e7imi etkenleri bu azalmay\u0131 yumu\u015fat\u0131r. Ara\u015ft\u0131rmalar uyarlanm\u0131\u015f yakla\u015f\u0131mlarla kar\u015f\u0131la\u015ft\u0131r\u0131labilir kazan\u0131mlar g\u00f6steriyor.<\/p>\n<\/div>\n<div class=\"faq-item\">\n<h3>BDT\u2019den gelen beyin de\u011fi\u015fimleri ne kadar s\u00fcrer?<\/h3>\n<p>BDT\u2019den gelen beyin de\u011fi\u015fimleri \u00e7o\u011fu zaman y\u0131llarca s\u00fcrer; izlem taramalar\u0131 terapiden be\u015f y\u0131l sonras\u0131na kadar kararl\u0131l\u0131k g\u00f6steriyor. S\u00fcrd\u00fcr\u00fcm seanslar\u0131 bunlar\u0131 peki\u015ftirir. Uzun s\u00fcreli \u00e7al\u0131\u015fmalar, tedavi g\u00f6rmeyen vakalara k\u0131yasla daha d\u00fc\u015f\u00fck n\u00fcks oran\u0131 g\u00f6steriyor.<\/p>\n<\/div>\n<div class=\"faq-item\">\n<h3>BDT ve n\u00f6roplastisiteden en \u00e7ok kimler yararlan\u0131r?<\/h3>\n<p>Kayg\u0131, depresyon ya da travma sonras\u0131 stres bozuklu\u011fu olan yeti\u015fkinler, \u00f6zellikle g\u00fcd\u00fclenmesi ve deste\u011fi y\u00fcksek olanlar en \u00e7ok yararlan\u0131r. E\u015flik eden durumlar da iyi yan\u0131t verir. Ki\u015fiselle\u015ftirilmi\u015f planlar t\u00fcm kesimlerde sonucu en \u00fcste \u00e7\u0131kar\u0131r.<\/p>\n<\/div>\n<div class=\"faq-item\">\n<h3>Terapiden gelen beyin de\u011fi\u015fimlerinin riski var m\u0131?<\/h3>\n<p>BDT\u2019nin riski \u00e7ok azd\u0131r; de\u011fi\u015fimler uyum sa\u011flay\u0131c\u0131 ve yararl\u0131d\u0131r. A\u015f\u0131r\u0131 uyar\u0131lma nadirdir ve terapistlerce y\u00f6netilir. \u0130zleme, olumsuz etki olmadan olumlu n\u00f6roplastisiteyi g\u00fcvenceye al\u0131r.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u0130\u00e7indekiler Understanding Cognitive Behavioral Therapy Fundamentals The Science Behind Neuroplasticity Mechanisms Linking Cognitive Behavioral Therapy and Neuroplasticity Evidence from Neuroimaging Studies on Brain Changes Specific Structural Brain Changes in Adult Patients Factors Influencing Neuroplasticity During CBT Clinical Implications for Treating\u2026<\/p>\n","protected":false},"author":0,"featured_media":16637,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[190,191,192,193,194,195,196,197],"class_list":["post-518","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-adult-patients","tag-brain-changes","tag-cognitive-behavioral-therapy","tag-mental-health-treatment","tag-neuroimaging-studies","tag-neuroplasticity","tag-neuroscience-research","tag-psychological-therapy"],"_links":{"self":[{"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/posts\/518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/comments?post=518"}],"version-history":[{"count":1,"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/posts\/518\/revisions"}],"predecessor-version":[{"id":14546,"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/posts\/518\/revisions\/14546"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/media\/16637"}],"wp:attachment":[{"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/media?parent=518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/categories?post=518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alienroad.com\/wp-json\/wp\/v2\/tags?post=518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}